Collaborative Group And Abbott Sign License Agreement

The Collaborative Group, Ltd., and Abbott Laboratories have signed a worldwide, exclusive license agreement granting Abbott access to Collaborative’s technology relating to fungal beta (1,3)-glucan detection reagents for human fungal diagnostic assay development and commercialization. The technology allows easy integration with a variety of diagnostic assay formats, and also provides improved performance over other existing Read more about Collaborative Group And Abbott Sign License Agreement[…]

Dow To Acquire Collaborative BioAlliance

The Dow Chemical Company has signed a definitive agreement to purchase The Collaborative Group’s Biotechnology Services Division, including all of the assets of Collaborative BioAlliance, Inc. (CBA) and Collaborative Smithfield Corp. Pending regulatory review and obtaining certain third-party consents, the acquisition is expected to close towards the end of November. The financial terms of the Read more about Dow To Acquire Collaborative BioAlliance[…]